Imidazolyl Lipids Enhanced LNP Endosomal Escape for Ferroptosis RNAi Treatment of Cancer
Small · 2024
DOI: 10.1002/smll.202402362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Yuanyuan Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of National Security Specially Needed Medicines, Beijing Institute of Pharmacology and Toxicology, 27 Tai-Ping Road, Beijing, 10…. Hauptthemen laut MEDLINE: Ferroptosis, RNA, Small Interfering, Nanoparticles, Lipids. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Treatments for cancer that incorporate small interfering RNA (siRNA) to target iron‐dependent ferroptosis are thought to be highly promising. However, creating a reliable and clinically feasible siRNA delivery system continues to be a major obstacle in the field of cancer treatment. Here, three imidazole‐based ionizable lipid nanoparticles (LNPs) with pH‐sensitive effects are rationally designed and synthesized for siRNA delivery. LNPs formulated with the top‐performing lipid (O12‐D3‐I3) encapsulating FVII siRNA (FVII@O‐LNP) elicited greater gene silencing than those with the benchmark Onpattro lipid DLin‐MC3‐DMA (MC3) due to its stronger endosomal escape. Moreover, Fc‐siRNA@O‐LNPs encapsulated with ferrocene (Fc) and SLC7A11/Nrf2‐targeted siRNA is formulated. The outcomes demonstrate optimal safety profiles and a significant anti‐tumor effect by inducing long‐lasting and efficient ferroptosis through a synergistic action in vivo. In summary, this work shows that imidazolyl lipid‐prepared LNPs are efficient delivery vehicles for cancer therapy and ferroptosis‐targeting siRNA administration, both of which have extensive clinical application potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of National Security Specially Needed Medicines, Beijing Institute of Pharmacology and Toxicology, 27 Tai-Ping Road, Beijing, 100850, China.
ORCID-Profile: Qingbin Meng
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, Y., He, F., Chen, L., Zhang, Y., Zhang, H., Xiao, J., & Meng, Q. (2024). Imidazolyl Lipids Enhanced LNP Endosomal Escape for Ferroptosis RNAi Treatment of Cancer. Small. https://doi.org/10.1002/smll.202402362
Vancouver
Liu Y, He F, Chen L, Zhang Y, Zhang H, Xiao J, et al. Imidazolyl Lipids Enhanced LNP Endosomal Escape for Ferroptosis RNAi Treatment of Cancer. Small. 2024. doi:10.1002/smll.202402362
BibTeX
@article{Liu2024,
author = {Liu, Yuanyuan and He, Fengyang and Chen, Longming and Zhang, Yahan and Zhang, Han and Xiao, Junhai and Meng, Qingbin},
title = {Imidazolyl Lipids Enhanced LNP Endosomal Escape for Ferroptosis RNAi Treatment of Cancer},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202402362}
}
EUVIMED